JOSHUA RUCH
CIK 943431 · last filed 2026-06-23
JOSHUA RUCH is a corporate insider who has filed 41 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for WGS, was dated Jun 23, 2026. Across all open-market trades the lifetime net is +$17.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $68.8M across reported positions. 38 SEC filings were submitted jointly with HABIB KAIROUZ.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$68.83M
8
41
$17.91M
Filer Profile
EAST QUOGUE, NY 11942
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WGS | Director | 45,240 | $85.99 | $3.89M | $0 | 1 | 2026-06-23 |
| GeneDx Holdings Corp. (WGSWW) Delisted | Director | 56,381 | $0.00 | $11 | -$6.09M | 12 | 2025-11-26 |
| GeneDx Holdings Corp. (SMFRW) Delisted | Director | 179,486 | $0.02 | $4.3K | $0 | 6 | 2022-10-18 |
| NephroGenex, Inc. (NRX) Delisted | Director | 1,326,826 | — | — | $0 | 1 | 2014-02-19 |
| VERENIUM CORP (VRNM) Delisted | Director | 482,211 | — | — | $0 | 11 | 2013-06-25 |
| GENVEC INC (GNVC) Delisted | Director | 34,776 | — | — | $0 | 6 | 2010-06-18 |
| ReachLocal Inc (RLOC) Delisted | 10%+ Owner | 3,331,966 | — | — | $24.00M | 1 | 2010-05-25 |
| BFLY | Director | 8,823,529 | $7.36 | $64.94M | $0 | 1 | 2010-02-26 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-23 | WGS | Mixed | +3,576 | $0 | EDGAR |
| 2025-11-26 | GeneDx Holdings Corp. (WGSWW) Delisted | Sell (S) | −38,000 | -$6.09M | EDGAR |
| 2025-11-24 | WGS | Notice (144) | −38,000 | -$6.09M | EDGAR |
| 2025-06-23 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +12,924 | $0 | EDGAR |
| 2025-02-07 | GeneDx Holdings Corp. (WGSWW) Delisted | Exer (M) | +5,816 | $45.9K | EDGAR |
| 2025-01-22 | GeneDx Holdings Corp. (WGSWW) Delisted | Exer (M) | +3,000 | $23.7K | EDGAR |
| 2024-11-21 | GeneDx Holdings Corp. (WGSWW) Delisted | — | — | $0 | EDGAR |
| 2024-10-17 | GeneDx Holdings Corp. (WGSWW) Delisted | Exer (M) | +130 | $0 | EDGAR |
| 2024-06-27 | GeneDx Holdings Corp. (WGSWW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | GeneDx Holdings Corp. (WGSWW) Delisted | Exer (M) | +5,828 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.